V. Jarlier

发表

Ready for a world without antibiotics? The Pensières Antibiotic Resistance Call to Action

Herman Goossens, Stephan Harbarth, Didier Pittet, 2012, Antimicrobial Resistance and Infection Control.

A surge of MDR and XDR tuberculosis in France among patients born in the Former Soviet Union.

V. Jarlier, C. Bernard, F. Brossier, 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Structural Insights into the Quinolone Resistance Mechanism of Mycobacterium tuberculosis DNA Gyrase

M. Delarue, V. Jarlier, C. Mayer, 2010, PloS one.

DNA Gyrase Inhibition Assays Are Necessary To Demonstrate Fluoroquinolone Resistance Secondary to gyrB Mutations in Mycobacterium tuberculosis

V. Jarlier, F. Brossier, C. Mayer, 2011, Antimicrobial Agents and Chemotherapy.

Extending the Definition of the GyrB Quinolone Resistance-Determining Region in Mycobacterium tuberculosis DNA Gyrase for Assessing Fluoroquinolone Resistance in M. tuberculosis

V. Jarlier, F. Brossier, N. Veziris, 2012, Antimicrobial Agents and Chemotherapy.

Curbing methicillin-resistant Staphylococcus aureus in 38 French hospitals through a 15-year institutional control program.

C. Brun-Buisson, J. Carlet, J. Lucet, 2010, Archives of internal medicine.

National multidrug-resistant bacteria (MDRB) surveillance in France through the RAISIN network: a 9 year experience.

V. Jarlier, B. Coignard, H. Sénéchal, 2013, The Journal of antimicrobial chemotherapy.

Ongoing increasing temporal and geographical trends of the incidence of extended-spectrum beta-lactamase-producing Enterobacteriaceae infections in France, 2009 to 2013.

V. Jarlier, P. Astagneau, I. Arnaud, 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis

Hinrich W. H. Göhlmann, Philip Timmerman, Jean-Marc Neefs, 2005, Science.

Structure of the imipenem-hydrolyzing class A beta-lactamase SME-1 from Serratia marcescens.

Thierry Naas, J. Delettré, P. Nordmann, 2002, Acta crystallographica. Section D, Biological crystallography.

Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey.

Herman Goossens, Ann Versporten, H. Goossens, 2018, The Lancet. Global health.

Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns.

V. Jarlier, A. Philippon, G. Fournier, 1988, Reviews of infectious diseases.

Escherichia coli and Staphylococcus aureus: bad news and good news from the European Antimicrobial Resistance Surveillance Network (EARS-Net, formerly EARSS), 2002 to 2009.

G Kahlmeter, C. Suetens, F. Baquero, 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Epidemiological differences between the UK and Ireland versus France in Staphylococcus aureus isolates resistant to fusidic acid from community-acquired skin and soft tissue infections.

V. Jarlier, R. Skov, A. Larsen, 2008, The Journal of antimicrobial chemotherapy.

A Comprehensive Evaluation of GeneLEAD VIII DNA Platform Combined to Deeplex Myc-TB® Assay to Detect in 8 Days Drug Resistance to 13 Antituberculous Drugs and Transmission of Mycobacterium tuberculosis Complex Directly From Clinical Samples

V. Jarlier, V. Enouf, W. Sougakoff, 2021, Frontiers in Cellular and Infection Microbiology.

In Vitro and In Vivo Activities of Rifampin, Streptomycin, Amikacin, Moxifloxacin, R207910, Linezolid, and PA-824 against Mycobacterium ulcerans

V. Jarlier, J. Robert, B. Ji, 2006, Antimicrobial Agents and Chemotherapy.

Purification, crystallization and preliminary X-ray diffraction experiments on the breakage-reunion domain of the DNA gyrase from Mycobacterium tuberculosis.

V. Jarlier, C. Mayer, J. Piton, 2009, Acta crystallographica. Section F, Structural biology and crystallization communications.

Purification and inhibition by quinolones of DNA gyrases from Mycobacterium avium, Mycobacterium smegmatis and Mycobacterium fortuitum bv. peregrinum.

V. Jarlier, W. Sougakoff, E. Cambau, 1999, Microbiology.

Correlation between Quinolone Susceptibility Patterns and Sequences in the A and B Subunits of DNA Gyrase in Mycobacteria

V. Jarlier, E. Cambau, I. Guillemin, 1998, Antimicrobial Agents and Chemotherapy.

Trends in quinolone susceptibility of Enterobacteriaceae among inpatients of a large university hospital: 1992-98.

V. Jarlier, J. Robert, M. Fievet, 2001, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

In vitro comparative activity of meropenem with 15 other antimicrobial agents against 1798 Pseudomonas aeruginosa isolates in a French multicenter study.

H. Richet, V. Jarlier, E. Lecaillon, 1999, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[What are the new diagnostic tools in tuberculosis? What is their role in disease management and what are their indications? Gene amplification tests].

V. Jarlier, W. Sougakoff, E. Cambau, 2004, Revue des maladies respiratoires.

Culture-independent prediction of isoniazid resistance in Mycobacterium tuberculosis by katG gene analysis directly from sputum samples.

K. Feldmann, S. Rüsch-Gerdes, V. Jarlier, 1999, Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology.

Novel Class A β-Lactamase Sed-1 fromCitrobacter sedlakii: Genetic Diversity of β-Lactamases within the Citrobacter Genus

V. Jarlier, W. Sougakoff, I. Casin, 2001, Antimicrobial Agents and Chemotherapy.

Purification, Crystallization, and Preliminary X-Ray Diffraction Analysis of the Carbapenem-Hydrolyzing Class A β-Lactamase Sme-1 fromSerratia marcescens

N. Colloc'h, J. Delettré, P. Nordmann, 1996 .

Purification, crystallization, and preliminary X-Ray diffraction analysis of the carbapenem-hydrolyzing class A beta-lactamase Sme-1 from Serratia marcescens.

N. Colloc'h, J. Delettré, P. Nordmann, 1996, Journal of structural biology.

Antibacterial Resistance, Wayampis Amerindians, French Guyana

V. Jarlier, A. Andremont, L. Armand-Lefèvre, 2004, Emerging infectious diseases.

Permeability of the mycobacterial cell wall.

H. Nikaido, V. Jarlier, 1991, Research in microbiology.

Use of a high-density DNA probe array for detecting mutations involved in rifampicin resistance in Mycobacterium tuberculosis.

V. Jarlier, W. Sougakoff, C. Truffot-Pernot, 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Drug resistance and HIV co-infection among pulmonary tuberculosis patients in Haiphong City, Vietnam.

V. Jarlier, J. Robert, N. Hung, 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Rapid emergence of Mycobacterium tuberculosis bedaquiline resistance: lessons to avoid repeating past errors

Y. Yazdanpanah, V. Jarlier, E. Caumes, 2017, European Respiratory Journal.

Synergistic Activity of R207910 Combined with Pyrazinamide against Murine Tuberculosis

K. Andries, V. Jarlier, N. Veziris, 2006, Antimicrobial Agents and Chemotherapy.

Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria

B. Berçot, V. Jarlier, C. Bernard, 2017, The Journal of antimicrobial chemotherapy.

Assessment of Clarithromycin Susceptibility in Strains Belonging to the Mycobacterium abscessus Group by erm(41) and rrl Sequencing

J. Gaillard, V. Jarlier, F. Brossier, 2010, Antimicrobial Agents and Chemotherapy.

Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients.

I. Pin, J. Gaillard, J. Herrmann, 2015, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Rapid Identification of Mycobacterial Whole Cells in Solid and Liquid Culture Media by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry

P. Berche, X. Nassif, J. Gaillard, 2010, Journal of Clinical Microbiology.

Assessing Primary and Secondary Resistance to Clarithromycin and Amikacin in Infections Due to Mycobacterium avium Complex

V. Jarlier, C. Bernard, F. Brossier, 2015, Antimicrobial Agents and Chemotherapy.

Significant Difference in Drug Susceptibility Distribution between Mycobacterium avium and Mycobacterium intracellulare

V. Jarlier, C. Bernard, N. Veziris, 2014, Journal of Clinical Microbiology.

In vivo evaluation of antibiotic activity against Mycobacterium abscessus.

J. Gaillard, V. Jarlier, N. Veziris, 2014, The Journal of infectious diseases.

Antibiotic Susceptibility Pattern ofMycobacterium marinum

S. Escolano, V. Jarlier, C. Truffot-Pernot, 2000, Antimicrobial Agents and Chemotherapy.

Molecular basis of clarithromycin activity against Mycobacterium avium and Mycobacterium smegmatis.

V. Jarlier, F. Doucet-Populaire, J. Capobianco, 1998, The Journal of antimicrobial chemotherapy.

A once-weekly R207910-containing regimen exceeds activity of the standard daily regimen in murine tuberculosis.

K. Andries, V. Jarlier, N. Veziris, 2009, American journal of respiratory and critical care medicine.

Efficient Intermittent Rifapentine-Moxifloxacin-Containing Short-Course Regimen for Treatment of Tuberculosis in Mice

V. Jarlier, N. Veziris, N. Lounis, 2005, Antimicrobial Agents and Chemotherapy.

Could the DiversiLab® semi-automated repetitive-sequence-based PCR be an acceptable technique for typing isolates of Pseudomonas aeruginosa? An answer from our experience and a review of the literature.

Q. Lu, J. Rouby, A. Combes, 2015, Canadian journal of microbiology.

Two concomitant but unrelated cases of Pasteurella multocida infection, including meningitis secondary to pituitary adenoma microsurgery.

V. Jarlier, F. Brossier, W. Sougakoff, 2010, Medecine et maladies infectieuses.

Increase in hospital-acquired bloodstream infections caused by extended spectrum β-lactamase-producing Escherichia coli in a large French teaching hospital

V. Jarlier, F. Brossier, W. Sougakoff, 2009, European Journal of Clinical Microbiology & Infectious Diseases.

Emergence and Spread in French Hospitals of Methicillin-Resistant Staphylococcus aureus with Increasing Susceptibility to Gentamicin and Other Antibiotics

F. Vandenesch, G. Lina, V. Jarlier, 1999, Journal of Clinical Microbiology.

Characterization of Gentamicin-Susceptible Strains of Methicillin-Resistant Staphylococcus aureus Involved in Nosocomial Spread

V. Jarlier, W. Sougakoff, M. Fievet, 1998, Journal of Clinical Microbiology.

Multiple cerebral abscesses as a complication of Mycobacterium fortuitum infection.

A. Laquérriere, V. Jarlier, C. Truffot-Pernot, 2003, European journal of internal medicine.

The EPISA study: antimicrobial susceptibility of Staphylococcus aureus causing primary or secondary skin and soft tissue infections in the community in France, the UK and Ireland.

V. Jarlier, M. Denton, B. O'Connell, 2008, The Journal of antimicrobial chemotherapy.

Evaluation of the Fluo-RAL Module for Detection of Tuberculous and Nontuberculous Acid-Fast Bacilli by Fluorescence Microscopy

V. Jarlier, C. Bernard, N. Veziris, 2013, Journal of Clinical Microbiology.

Growth on blood agar discriminates Mycobacterium avium and Mycobacterium intracellulare.

M. Drancourt, V. Jarlier, C. Truffot, 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Daptomycin is not active against rapidly growing mycobacteria.

V. Jarlier, F. Brossier, N. Veziris, 2010, Journal of medical microbiology.

Chemotherapy-Associated Changes of Histopathological Features of Mycobacterium ulcerans Lesions in a Buruli Ulcer Mouse Model

G. Pluschke, V. Jarlier, B. Ji, 2011, Antimicrobial Agents and Chemotherapy.

Bactericidal Activity of Rifampin-Amikacin against Mycobacterium ulcerans in Mice

V. Jarlier, J. Robert, Abdelhalim Bentoucha, 2002, Antimicrobial Agents and Chemotherapy.

Amplification and nucleotide sequence of the quinolone resistance-determining region in the gyrA gene of mycobacteria.

V. Jarlier, W. Sougakoff, E. Cambau, 1994, FEMS microbiology letters.

Aspects histopathologiques de l’infection à Mycobacterium marinum

O. Chosidow, V. Jarlier, E. Caumes, 2011 .

Multidrug and extensively drug-resistant tuberculosis Tuberculoses à bacilles multi-et ultrarésistants

V. Jarlier, C. Bernard, F. Brossier, 2017 .

Synthase C-Ring Structure the Diarylquinoline TMC 207 to the ATP Synthase : New Insights into the Binding of New Mutations in the Mycobacterial ATP

V. Jarlier, W. Sougakoff, S. Petrella, 2012 .

Sterilizing activity of R207910 (TMC207)-containing regimens in the murine model of tuberculosis.

K. Andries, V. Jarlier, N. Veziris, 2009, American journal of respiratory and critical care medicine.

Combinations of R207910 with Drugs Used To Treat Multidrug-Resistant Tuberculosis Have the Potential To Shorten Treatment Duration

K. Andries, V. Jarlier, N. Veziris, 2006, Antimicrobial Agents and Chemotherapy.

Bactericidal Activities of R207910 and Other Newer Antimicrobial Agents against Mycobacterium leprae in Mice

K. Andries, V. Jarlier, B. Ji, 2006, Antimicrobial Agents and Chemotherapy.

Are moxifloxacin and levofloxacin equally effective to treat XDR tuberculosis?

V. Jarlier, C. Bernard, N. Veziris, 2017, The Journal of antimicrobial chemotherapy.

Rifampicin mono-resistant tuberculosis in France: a 2005–2010 retrospective cohort analysis

V. Jarlier, N. Veziris, J. Robert, 2014, BMC Infectious Diseases.

An intervention programme for the management of multidrug-resistant tuberculosis in France.

B. Dautzenberg, V. Jarlier, J. Robert, 2007, International journal of antimicrobial agents.

Comparison of a Semiautomated Commercial Repetitive-Sequence-Based PCR Method with Spoligotyping, 24-Locus Mycobacterial Interspersed Repetitive-Unit–Variable-Number Tandem-Repeat Typing, and Restriction Fragment Length Polymorphism-Based Analysis of IS6110 for Mycobacterium tuberculosis Typing

V. Jarlier, F. Brossier, W. Sougakoff, 2014, Journal of Clinical Microbiology.

Performance of the Genotype MTBDR Line Probe Assay for Detection of Resistance to Rifampin and Isoniazid in Strains of Mycobacterium tuberculosis with Low- and High-Level Resistance

V. Jarlier, F. Brossier, W. Sougakoff, 2006, Journal of Clinical Microbiology.

Characterization of mutations in Mycobacterium smegmatis involved in resistance to fluoroquinolones

V. Jarlier, W. Sougakoff, E. Cambau, 1994, Antimicrobial Agents and Chemotherapy.

Sequences of conserved region in the A subunit of DNA gyrase from nine species of the genus Mycobacterium: phylogenetic analysis and implication for intrinsic susceptibility to quinolones

V. Jarlier, E. Cambau, I. Guillemin, 1995, Antimicrobial agents and chemotherapy.

Outbreak of tuberculosis in a migrants' shelter, Paris, France, 2002.

B. Dautzenberg, V. Jarlier, W. Sougakoff, 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Nosocomial bronchopneumonia in the critically ill. Histologic and bacteriologic aspects.

J. Rouby, V. Jarlier, J. Grosset, 1992, The American review of respiratory disease.

Society's failure to protect a precious resource: antibiotics

H. Goossens, D. Pittet, P. Collignon, 2011, The Lancet.

Characterization of the chromosomal class A beta-lactamase CKO from Citrobacter koseri.

V. Jarlier, W. Sougakoff, S. Petrella, 2006, FEMS microbiology letters.

The Environmental Pathogen Mycobacterium ulcerans Grows in Amphibian Cells at Low Temperatures

D. Raoult, M. Drancourt, V. Jarlier, 2002, Applied and Environmental Microbiology.

Nosocomial transmission of tuberculosis among mentally-handicapped patients in a long-term care facility.

V. Jarlier, W. Sougakoff, J. Grosset, 1996, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[Enterobacter cloacae. In vivo emergence of a variant resistant to new beta-lactams during treatment with lamoxactam-gentamicin].

G. Paul, V. Jarlier, A. Philippon, 1984, Pathologie-biologie.

Characterization of New Mutations in Pyrazinamide-Resistant Strains of Mycobacterium tuberculosisand Identification of Conserved Regions Important for the Catalytic Activity of the Pyrazinamidase PncA

V. Jarlier, W. Sougakoff, C. Truffot-Pernot, 1999, Antimicrobial Agents and Chemotherapy.

Detection by Genotype MTBDRsl test of complex resistance

V. Jarlier, F. Brossier, N. Veziris, 2010 .

Detection by GenoType MTBDRsl Test of Complex Mechanisms of Resistance to Second-Line Drugs and Ethambutol in Multidrug-Resistant Mycobacterium tuberculosis Complex Isolates

V. Jarlier, F. Brossier, W. Sougakoff, 2010, Journal of Clinical Microbiology.

Comparative study of enzymatic activities of new KatG mutants from low- and high-level isoniazid-resistant clinical isolates of Mycobacterium tuberculosis.

V. Jarlier, F. Brossier, W. Sougakoff, 2016, Tuberculosis.

Characterization of a Clone of Mycobacterium tuberculosis Clinical Isolates with Mutations in KatG (A110V), EthA (Q269STOP), and the inhA Promoter (−15C→T)

V. Jarlier, C. Bernard, F. Brossier, 2015, Journal of Clinical Microbiology.

Nonradioactive single-strand conformation polymorphism analysis for detection of fluoroquinolone resistance in Mycobacteria

V. Jarlier, W. Sougakoff, E. Cambau, 1997, European Journal of Clinical Microbiology and Infectious Diseases.

Resistance to quinolones in mycobacteria.

V. Jarlier, E. Cambau, 1996, Research in microbiology.

Selection of a gyrA mutant of Mycobacterium tuberculosis resistant to fluoroquinolones during treatment with ofloxacin.

V. Jarlier, W. Sougakoff, C. Truffot-Pernot, 1994, The Journal of infectious diseases.

Multidrug-resistant tuberculosis: eight years of surveillance in France

V. Jarlier, J. Robert, C. Truffot-Pernot, 2003, European Respiratory Journal.

Mycobacterial Growth Indicator Tube Versus the Proportion Method on Löwenstein-Jensen Medium for Antibiotic Susceptibility Testing of Mycobacterium tuberculosis

V. Jarlier, C. Truffot-Pernot, J. Grosset, 2000, European Journal of Clinical Microbiology and Infectious Diseases.

Outcome of multi-drug-resistant tuberculosis in France: a nationwide case-control study.

V. Jarlier, J. Robert, J. Grosset, 1999, American journal of respiratory and critical care medicine.

Molecular characterisation of isoniazid-resistant Mycobacterium tuberculosis isolated from new cases in Lagunes region (Côte d'Ivoire).

V. Jarlier, J. Kouakou, E. Ekaza, 2008, International journal of antimicrobial agents.

Performance of MTBDR plus for detecting high/low levels of Mycobacterium tuberculosis resistance to isoniazid.

V. Jarlier, F. Brossier, W. Sougakoff, 2009, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[New diagnostic tools for tuberculosis: the revolution is not over].

V. Jarlier, N. Veziris, 2004, Revue des maladies respiratoires.

Surveillance of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae producing extended-spectrum beta-lactamase (ESBLE) in Northern France: a five-year multicentre incidence study.

P. Cahen, V. Jarlier, J. Koeck, 2002, The Journal of hospital infection.

Interpreting Susceptibility Testing of Carbapenem Against Pseudomonas aeruginosa

Q. Lu, V. Jarlier, F. Brossier, 2016, JSM Microbiology.

Draft Could the Diversilab ® semi-automated repetitive-sequence-based PCR be an acceptable technique for typing isolates of Pseudomonas aeruginosa ? An answer from our experience and a review of the literature

Q. Lu, J. Rouby, A. Combes, 2015 .

Ruling out False-Positive Urinary Legionella pneumophila Serogroup 1 and Streptococcus pneumoniae Antigen Test Results by Heating Urine

V. Jarlier, F. Brossier, A. Aubry, 2014, Journal of Clinical Microbiology.

Interplay of cell wall barrier and beta-lactamase activity determines high resistance to beta-lactam antibiotics in Mycobacterium chelonae

H. Nikaido, L. Gutmann, V. Jarlier, 1991, Antimicrobial Agents and Chemotherapy.

Neither genotyping nor contact tracing allow correct understanding of multidrug-resistant tuberculosis transmission

V. Jarlier, C. Bernard, W. Sougakoff, 2017, European Respiratory Journal.

Bactericidal and Sterilizing Activities of Several Orally Administered Combined Regimens against Mycobacterium ulcerans in Mice

V. Jarlier, J. Robert, B. Ji, 2008, Antimicrobial Agents and Chemotherapy.

Orally Administered Combined Regimens for Treatment of Mycobacterium ulcerans Infection in Mice

V. Jarlier, J. Robert, B. Ji, 2007, Antimicrobial Agents and Chemotherapy.

Selective reporting of antibiotic susceptibility test results in European countries: an ESCMID cross-sectional survey.

V. Jarlier, E. Tacconelli, G. Kahlmeter, 2017, International journal of antimicrobial agents.

Fluoroquinolone-Containing Third-Line Regimen against Mycobacterium tuberculosis In Vivo

V. Jarlier, N. Veziris, N. Lounis, 2003, Antimicrobial Agents and Chemotherapy.

Concomitant Multidrug-resistant Pulmonary Tuberculosis and Susceptible Tuberculous Meningitis

V. Jarlier, C. Bernard, F. Brossier, 2014, Emerging infectious diseases.

Antibiotic Susceptibility Pattern of Mycobacterium marinum

S. Escolano, V. Jarlier, C. Truffot-Pernot, 2000 .

Complete nucleotide sequence of the large conjugative pTC2 multireplicon plasmid encoding the VIM-1 metallo-β-lactamase.

L. Frangeul, V. Jarlier, W. Sougakoff, 2013, The Journal of antimicrobial chemotherapy.

Type II Topoisomerase Mutations in Ciprofloxacin-Resistant Strains of Pseudomonas aeruginosa

V. Jarlier, E. Cambau, J. Robert, 1999, Antimicrobial Agents and Chemotherapy.

Outbreak of Burkholderia cepacia Bacteremia in a Pediatric Hospital Due to Contamination of Lipid Emulsion Stoppers

E. Bingen, J. Fontan, V. Jarlier, 2004, Journal of Clinical Microbiology.

Epidemiology of Invasive Methicillin-Resistant Staphylococcus aureus Clones Collected in France in 2006 and 2007

F. Vandenesch, G. Lina, V. Jarlier, 2008, Journal of Clinical Microbiology.

The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System.

M. D. Kraker, H. Grundmann, V. Jarlier, 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

French recommendations for the prevention of 'emerging extensively drug-resistant bacteria' (eXDR) cross-transmission.

J. Lucet, V. Jarlier, S. Fournier, 2015, The Journal of hospital infection.

In Vitro Activities of Ertapenem (MK-0826) against Recent Clinical Bacteria Collected in Europe and Australia

F. Baquero, R. Zbinden, H. Endtz, 2001, Antimicrobial Agents and Chemotherapy.

Laser flare photometry in the therapeutic management of bacterial chronic pseudophakic endophthalmitis

V. Jarlier, P. Lehoang, C. Fardeau, 2009, Journal of cataract and refractive surgery.

Decreased susceptibility to glycopeptides in methicillin-resistant Staphylococcus aureus: a 20 year study in a large French teaching hospital, 1983-2002.

V. Jarlier, J. Robert, R. Bismuth, 2006, The Journal of antimicrobial chemotherapy.

Surveillance of the current resistance of nosocomial pathogens to antibacterials

R. Spencer, J. Turnidge, V. Jarlier, 1997 .

Broad-range PCR: past, present, or future of bacteriology?

V. Jarlier, F. Brossier, W. Sougakoff, 2013, Medecine et maladies infectieuses.

First multicenter study on multidrug resistant bacteria carriage in Chinese ICUs

V. Jarlier, J. Robert, Xiaojun Ma, 2015, BMC Infectious Diseases.

Prevention of Gram negative noscomial bronchopneumonia by intratracheal colistin in critically ill patients

J. Rouby, V. Jarlier, P. Viars, 1994, Intensive Care Medicine.

[Nosocomial influenza outbreak in a geriatrics department: Effectiveness of preventive measures].

V. Jarlier, J. Belmin, A. Andrieu, 2006, Presse medicale.

Cloxacillin versus Pristinamycin for Superficial Pyodermas: A Randomized, Open-Label, Non-Inferiority Study

P. Humbert, O. Chosidow, V. Jarlier, 2005, Dermatology.

Good interpretation of the results of a diagnostic test.

V. Jarlier, N. Veziris, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Estimating the morbidity and mortality associated with infections due to multidrug-resistant bacteria (MDRB), France, 2012

C. Brun-Buisson, V. Jarlier, B. Coignard, 2016, Antimicrobial Resistance and Infection Control.

Antibiotic susceptibility in aerobic gram-negative bacilli isolated in intensive care units in 39 French teaching hospitals (ICU study)

V. Jarlier, A. Philippon, T. Fosse, 1996, Intensive Care Medicine.

Detection of OXA-48-like carbapenemase genes by the Xpert® Carba-R test: room for improvement.

V. Jarlier, W. Sougakoff, J. Robert, 2015, International journal of antimicrobial agents.

Dissemination in five French hospitals ofKlebsiella pneumoniae serotype K25 harbouring a new transferable enzymatic resistance to third generation cephalosporins and aztreonam

G. Paul, V. Jarlier, A. Philippon, 1988, European Journal of Clinical Microbiology and Infectious Diseases.

Interpreting carbapenem susceptibility testing results for Pseudomonas aeruginosa.

Q. Lu, V. Jarlier, F. Brossier, 2018, Medecine et maladies infectieuses.

Contribution of ParE Mutation and Efflux to Ciprofloxacin Resistance in Pseudomonas aeruginosa Clinical Isolates

V. Jarlier, A. Aubry, E. Cambau, 2008, Journal of chemotherapy.

Role of mutations in DNA gyrase genes in ciprofloxacin resistance of Pseudomonas aeruginosa susceptible or resistant to imipenem

V. Jarlier, J. Trias, E. Cambau, 1995, Antimicrobial agents and chemotherapy.

An evaluation of data quality in a network for surveillance of Mycobacterium tuberculosis resistance to antituberculosis drugs in Ile-de-France region-2001–2002

V. Jarlier, J. Robert, D. Che, 2006, European Journal of Epidemiology.

Implementation of isolation precautions: role of a targeted information flyer.

V. Jarlier, J. Robert, K. Grenet, 2006, The Journal of hospital infection.

Presence of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) of Staphylococcus aureus in France—joint authors' response

V. Jarlier, R. Skov, M. Denton, 2008 .

Characteristics of human intestinal Escherichia coli with changing environments.

E. Denamur, J. Boutin, J. Mohler, 2008, Environmental microbiology.

Porins in the cell wall of mycobacteria.

R. Benz, V. Jarlier, J. Trias, 1992, Science.

French National Program for Prevention of Healthcare-Associated Infections and Antimicrobial Resistance, 1992–2008: Positive Trends, But Perseverance Needed

J. Desenclos, C. Brun-Buisson, J. Carlet, 2009, Infection Control & Hospital Epidemiology.

Expression and Puriﬁcation of an Active Form of the Mycobacterium leprae DNA Gyrase and Its Inhibition by Quinolones (cid:1)

V. Jarlier, W. Sougakoff, S. Petrella, 2007 .

First Evaluation of Drug-Resistant Mycobacterium tuberculosis Clinical Isolates from Congo Revealed Misdetection of Fluoroquinolone Resistance by Line Probe Assay Due to a Double Substitution T80A-A90G in GyrA

V. Jarlier, W. Sougakoff, R. Courcol, 2014, PloS one.

Role of ser-237 in the substrate specificity of the carbapenem-hydrolyzing class A beta-lactamase Sme-1.

P. Nordmann, T. Naas, V. Jarlier, 1999, Biochimica et biophysica acta.

Trends in Antibiotic Consumption and Resistance in France Over 20 Years: Large and Continuous Efforts but Contrasting Results

G. Lina, J. Carlet, C. Rambaud, 2020, Open forum infectious diseases.

Impact of a 14-year screening programme on tuberculosis transmission among the homeless in Paris.

V. Jarlier, C. Bernard, F. Brossier, 2012, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Efficiency of different control measures for preventing carbapenemase-producing enterobacteria and glycopeptide-resistant Enterococcus faecium outbreaks: a 6-year prospective study in a French multihospital institution, January 2010 to December 2015

V. Jarlier, S. Fournier, C. Richard, 2018, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

ECDC, EFSA and EMA Joint Scientific Opinion on a list of outcome indicators as regards surveillance of antimicrobial resistance and antimicrobial consumption in humans and food‐producing animals

Stephen C. Spiteri, N. Speybroeck, B. Nørrung, 2017, EFSA journal. European Food Safety Authority.

Impact of the BCG vaccination policy on tuberculous meningitis in children under 6 years in metropolitan France between 2000 and 2011.

D. Levy-bruhl, V. Jarlier, J. Robert, 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Increase in primary drug resistance of Mycobacterium tuberculosis in younger birth cohorts in France.

V. Jarlier, N. Veziris, J. Robert, 2012, The Journal of infection.

A 10-year prospective surveillance of Mycobacterium tuberculosis drug resistance in France 1995–2004

V. Jarlier, J. Robert, C. Truffot-Pernot, 2007, European Respiratory Journal.

Should Moxiﬂoxacin Be Used for the Treatment of Extensively Drug-Resistant Tuberculosis? An Answer from a Murine Model (cid:1)

R. Farinotti, V. Jarlier, N. Veziris, 2010 .

Organization and training at national level of antimicrobial stewardship and infection control activities in Europe: an ESCMID cross-sectional survey

A. Barać, W. Zingg, A. Holmes, 2019, European Journal of Clinical Microbiology & Infectious Diseases.

Use of DNA fingerprinting for primary surveillance of nosocomial tuberculosis in a large urban hospital: detection of outbreaks in homeless people and migrant workers.

V. Jarlier, W. Sougakoff, C. Truffot-Pernot, 1998, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Spontaneous ascitic fluid infection and bacteremia due to Yersinia pseudotuberculosis in a liver transplant patient.

D. Thabut, L. Epelboin, V. Jarlier, 2015, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Fully weekly antituberculosis regimen: a proof-of-concept study

K. Andries, V. Jarlier, N. Veziris, 2020, European Respiratory Journal.

XDR-tuberculosis in France: Community transmission due to non-compliance with isolation precautions.

V. Jarlier, E. Caumes, C. Bernard, 2016, Medecine et maladies infectieuses.

Molecular Investigation of Resistance to Second-Line Injectable Drugs in Multidrug-Resistant Clinical Isolates of Mycobacterium tuberculosis in France

V. Jarlier, C. Bernard, F. Brossier, 2016, Antimicrobial Agents and Chemotherapy.

Comparative potency of mecillinam and other β-lactam antibiotics against Escherichia coli strains producing different β-lactamases

V. Jarlier, W. Sougakoff, 2000 .

Sequence analysis, purification, and study of inhibition by 4-quinolones of the DNA gyrase from Mycobacterium smegmatis

V. Jarlier, W. Sougakoff, V. Revel-Viravau, 1996, Antimicrobial agents and chemotherapy.

Mycobacterium tuberculosis DNA Gyrase: Interaction with Quinolones and Correlation with Antimycobacterial Drug Activity

V. Jarlier, L. Fisher, A. Aubry, 2004, Antimicrobial Agents and Chemotherapy.

Synthesis of gatifloxacin derivatives and their biological activities against Mycobacterium leprae and Mycobacterium tuberculosis.

A. Lamouri, Prishila Ponien, V. Jarlier, 2013, Bioorganic & medicinal chemistry.

[Acute localized pneumopathies. Should macrolides always be prescribed initially?].

B. Dautzenberg, V. Jarlier, M. Fievet, 1985, Presse medicale.

Surveillance of antimicrobial resistance--what, how and whither?

V. Isham, H. Goossens, M. Struelens, 2001, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

First functional characterization of a singly expressed bacterial type II topoisomerase: the enzyme from Mycobacterium tuberculosis.

Alexandra Aubry, V. Jarlier, L. Fisher, 2006, Biochemical and biophysical research communications.

The Pentapeptide Repeat Proteins MfpAMt and QnrB4 Exhibit Opposite Effects on DNA Gyrase Catalytic Reactions and on the Ternary Gyrase-DNA-Quinolone Complex

V. Jarlier, A. Aubry, S. Matrat, 2008, Journal of bacteriology.

European recommendations for antimicrobial resistance surveillance.

F. Baquero, G. Cornaglia, V. Jarlier, 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Outbreak of Nontuberculous Mycobacterial Subcutaneous Infections Related to Multiple Mesotherapy Injections

Eric Caumes, Jean-Paul Meningaud, Pascal Astagneau, 2009, Journal of Clinical Microbiology.

Molecular genetic analysis of cephalosporinase production and its role in beta-lactam resistance in clinical isolates of Enterobacter cloacae

S. Cole, N. Honoré, V. Jarlier, 1987, Antimicrobial Agents and Chemotherapy.

[Antibiogram Committee of the French Microbiology Society. Report 2000-2001].

G Carret, J Sirot, V. Jarlier, 2000, Pathologie-biologie.

Occurrence of qnrA-positive clinical isolates in French teaching hospitals during 2002-2005.

L. Gutmann, V. Jarlier, R. Bonnet, 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Priority actions to fight antibiotic resistance: results of an international meeting

H. Goossens, D. Pittet, J. Mcgowan, 2012, Antimicrobial Resistance and Infection Control.

Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide.

V. Jarlier, F. Brossier, W. Sougakoff, 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Evaluation of the βLacta Test, a Rapid Test Detecting Resistance to Third-Generation Cephalosporins in Clinical Strains of Enterobacteriaceae

V. Jarlier, I. Podglajen, A. Renvoisé, 2013, Journal of Clinical Microbiology.

Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts.

J. Campos, Y. Carmeli, D. Livermore, 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Diabetic foot ulcer and multidrug‐resistant organisms: risk factors and impact

V. Jarlier, J. Robert, S. Jacqueminet, 2004, Diabetic medicine : a journal of the British Diabetic Association.

Twenty years of antimicrobial resistance control programme in a regional multi hospital institution, with focus on emerging bacteria (VRE and CPE)

C. Brun-Buisson, V. Jarlier, S. Fournier, 2012, Antimicrobial Resistance and Infection Control.

Survey of the phenotypes of susceptibility to beta-lactams in Enterobacteriaceae at the Pitie-Salpetriere Hospital.

V. Jarlier, J. Grosset, J. Nguyen, 1984, The Journal of antimicrobial chemotherapy.

Quantitative evaluation of extended-spectrum β-lactamase-producing Escherichia coli strains in the wastewater of a French teaching hospital and relation to patient strain

L. Moulin, V. Jarlier, S. Haenn, 2016, Antimicrobial Resistance & Infection Control.

Molecular detection of rifampin and ofloxacin resistance for patients who experience relapse of multibacillary leprosy.

V. Jarlier, W. Sougakoff, B. Ji, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Staphylococcus aureus bloodstream infections: diverging trends of meticillin-resistant and meticillin-susceptible isolates, EU/EEA, 2005 to 2018

T. Eckmanns, M. Monaco, A. Petersen, 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Comparison of Nine Phenotypic Methods for Detection of Extended-Spectrum β-Lactamase Production by Enterobacteriaceae

J. Golmard, V. Jarlier, J. Robert, 2011, Journal of Clinical Microbiology.

Extended measures for controlling an outbreak of VIM-1 producing imipenem-resistant Klebsiella pneumoniae in a liver transplant centre in France, 2003-2004.

D. Samuel, V. Jarlier, F. Saliba, 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Lack of additive effect between mechanisms of resistance to carbapenems and other beta-lactam agents inPseudomonas aeruginosa

V. Jarlier, J. Trias, C. Dib, 1995, European Journal of Clinical Microbiology and Infectious Diseases.

Antimicrobial resistance: one world, one fight!

H. Goossens, D. Pittet, A. van Belkum, 2015, Antimicrobial Resistance and Infection Control.

Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum

S. Cosgrove, H. Goossens, D. Pittet, 2013, Antimicrobial Resistance and Infection Control.

Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study.

D. Valla, S. Escolano, V. Jarlier, 1995, Gastroenterology.

Mycobacterial cell wall: structure and role in natural resistance to antibiotics.

H. Nikaido, V. Jarlier, H Nikaido, 1994, FEMS microbiology letters.

New Mutations in the Mycobacterial ATP Synthase: New Insights into the Binding of the Diarylquinoline TMC207 to the ATP Synthase C-Ring Structure

E. Segala, V. Jarlier, W. Sougakoff, 2012, Antimicrobial Agents and Chemotherapy.

Permeability barrier to hydrophilic solutes in Mycobacterium chelonei

H. Nikaido, V. Jarlier, H Nikaido, 1990, Journal of bacteriology.

Link between carbapenemase-producing Enterobacteria carriage and cross-border exchanges: eight-year surveillance in a large French multihospitals institution.

C. Brun-Buisson, V. Jarlier, S. Fournier, 2012, Journal of travel medicine.

Gentamicin-Susceptible or Gentamicin-Resistant Methicillin-Resistant Staphylococcus aureus A Case-Case Study

V. Jarlier, J. Robert, N. Lemaître, 2006, Infection Control & Hospital Epidemiology.

Activity of Carbapenems Combined with Clavulanate against Murine Tuberculosis

J. Mainardi, V. Jarlier, N. Veziris, 2011, Antimicrobial Agents and Chemotherapy.

Extended-spectrum β-lactamases in long-term-care facilities

V. Jarlier, M. Nicolas-Chanoine, 2008 .

Carriage of methicillin-resistant Staphylococcus aureus in home care settings: prevalence, duration, and transmission to household members.

France Mentré, Xavier Paoletti, Antoine Andremont, 2009, Archives of internal medicine.

French Intensive Care Society, International congress – Réanimation 2016

Paul P. Tallon, Stéphane Huot, B. Souweine, 2016, Annals of Intensive Care.

False-positive pneumococcal antigen test in a case of Enterococcus faecalis meningitis.

L. Epelboin, V. Jarlier, F. Brossier, 2013, Médecine et maladies infectieuses.

Decrease in the incidence of culture-positive meningitis and cerebral tuberculomas in France from 1990 to 2007

P. Boelle, V. Jarlier, J. Robert, 2013, Epidemiology and Infection.

Illustration of the Difficulty of Identifying Streptococcus equi Strains at the Subspecies Level through a Case of Endocarditis in an Immunocompetent Man

Alexandra Aubry, V. Jarlier, F. Brossier, 2013, Journal of Clinical Microbiology.

Detection of extended broad-spectrum beta-lactamases inEnterobacteriaceae in four French hospitals

J. Duval, V. Jarlier, A. Philippon, 1989, European Journal of Clinical Microbiology and Infectious Diseases.

Changing patterns of disseminated gonococcal infection in France: cross-sectional data 2009–2011

V. Jarlier, E. Caumes, O. Patey, 2013, Sexually Transmitted Infections.

Healthcare-associated infections: think globally, act locally.

H. Goossens, F. Baquero, D. Pittet, 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

The Global Point Prevalence Survey of Antimicrobial Consumption and Resistance (Global-PPS): A Worldwide Antimicrobial Web-Based Point Prevalence Survey

H. Goossens, D. Nathwani, V. Jarlier, 2015 .

Long-term control of vancomycin-resistant Enterococcus faecium at the scale of a large multihospital institution: a seven-year experience.

C. Brun-Buisson, J. Lucet, J. Zahar, 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Accumulation of carbapenemase-producing Gram-negative bacteria in a single patient linked to the acquisition of multiple carbapenemase producers and to the in vivo transfer of a plasmid encoding VIM-1.

V. Jarlier, W. Sougakoff, F. Doucet-Populaire, 2011, International journal of antimicrobial agents.

Emergence of carbapenemase-producing Enterobacteriaceae in France, 2004 to 2011.

V. Jarlier, B. Coignard, A. Carbonne, 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Control of a Multi-hospital Outbreak of Kpc-producing

V. Jarlier, M. Tavolacci, B. Coignard, 2009 .

Rapid control of an outbreak of vancomycin-resistant enterococci in a French university hospital.

A. Macrez, J. Lucet, C. Leport, 2007, The Journal of hospital infection.

A case-control study for multidrug-resistant tuberculosis: risk factors in four European countries.

S. Rüsch-Gerdes, V. Jarlier, J. Grosset, 2005, Microbial drug resistance.

Targeting the Mycobacterium ulcerans cytochrome bc1:aa3 for the treatment of Buruli ulcer

M. Tanner, G. Grüber, M. Witschel, 2018, Nature Communications.

Role of residues 104, 164, 166, 238 and 240 in the substrate profile of PER-1 beta-lactamase hydrolysing third-generation cephalosporins.

P. Nordmann, T. Naas, V. Jarlier, 1998, The Biochemical journal.

Bordetella bronchiseptica Pneumonia in a Woman with Lymphoma: A Case Report

Z. Amoura, V. Jarlier, F. Brossier, 2012 .

Molecular characterization of the gene encoding SHV-3 beta-lactamase responsible for transferable cefotaxime resistance in clinical isolates of Klebsiella pneumoniae

S. Cole, N. Honoré, V. Jarlier, 1989, Antimicrobial Agents and Chemotherapy.

Comment on: Redefining extended-spectrum beta-lactamases: balancing science and clinical need.

V. Miriagou, R. Bonomo, G. Jacoby, 2009, The Journal of antimicrobial chemotherapy.

Site-directed mutagenesis of residues 164, 170, 171, 179, 220, 237 and 242 in PER-1 beta-lactamase hydrolysing expanded-spectrum cephalosporins.

V. Jarlier, W. Sougakoff, A. Bouthors, 1999, Protein engineering.

Amino acid substitutions at positions 69, 165, 244 and 275 of the PER-1beta-lactamase do not impair enzyme inactivation by clavulanate.

V. Jarlier, W. Sougakoff, A. Bouthors, 1998, The Journal of antimicrobial chemotherapy.

Study of the structure-activity relationships for the pyrazinamidase (PncA) from Mycobacterium tuberculosis.

I. Callebaut, V. Jarlier, W. Sougakoff, 2001, The Biochemical journal.

Poor Performance of Rapid Molecular Tests to Define Eligibility for the Shortcourse Multidrug-resistant Tuberculosis Regimen.

V. Jarlier, F. Brossier, W. Sougakoff, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Analysis of β-lactamases produced by cephalothin-susceptible Escherichia coli clinical isolates resistant to co-amoxiclav and ticarcillin-clavulanic acid

G. Paul, V. Jarlier, H. Chardon, 1995 .

Extended-spectrum beta-lactamases in long-term-care facilities.

V. Jarlier, M. Nicolas-Chanoine, 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Phylogenetic Distribution of CTX-M- and Non-Extended-Spectrum-β-Lactamase-Producing Escherichia coli Isolates: Group B2 Isolates, Except Clone ST131, Rarely Produce CTX-M Enzymes

S. Brisse, V. Jarlier, M. Nicolas-Chanoine, 2012, Journal of Clinical Microbiology.

[Surveillance of multiresistant bacteria: justification, role of the laboratory, indicators, and recent French data].

V. Jarlier, L. Marty, 1998, Pathologie-biologie.

Patient's Origin and Lifestyle Associated with CTX-M-Producing Escherichia coli: A Case-Control-Control Study

V. Jarlier, B. Larroque, J. Robert, 2012, PloS one.

Strong correlation between the rates of intrinsically antibiotic-resistant species and the rates of acquired resistance in Gram-negative species causing bacteraemia, EU/EEA, 2016

J. Campos, T. Eckmanns, A. Pantosti, 2019, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

A national survey of human Mycobacterium bovis infection in France. Network of Microbiology Laboratories in France.

V. Jarlier, J. Robert, C. Truffot-Pernot, 1999, The International Journal of Tuberculosis and Lung Disease.

[Peritonitis during continuous ambulatory peritoneal dialysis. Lavage treatment or not? A prospective study].

V. Jarlier, J. Rottembourg, M. Legrain, 1983, Nephrologie.

Antimicrobial resistance: one world, one fight!

Herman Goossens, Stephan Harbarth, Didier Pittet, 2015, Antimicrobial Resistance and Infection Control.

Impact of an Acinetobacter baumannii outbreak on kidney events in a burn unit: A targeted machine learning analysis

A. Mebazaa, M. Mimoun, R. Pirracchio, 2019, American journal of infection control.

Crystal structures of the class D beta-lactamase OXA-13 in the native form and in complex with meropenem.

J. Delettré, V. Jarlier, W. Sougakoff, 2001, Journal of molecular biology.

Decrease of hospital- and community-acquired bloodstream infections due to Streptococcus pneumoniae and Streptococcus pyogenes during the first year of the COVID-19 pandemic: A time-series analysis in Paris region

V. Jarlier, X. Raynaud, J. Robert, 2022, American Journal of Infection Control.

Resistance of M. leprae to Quinolones: A Question of Relativity?

S. Escolano, V. Jarlier, N. Veziris, 2013, PLoS neglected tropical diseases.

Surging bloodstream infections and antimicrobial resistance during the first wave of COVID–19: a study in a large multihospital institution in the Paris region

R. Porcher, V. Jarlier, J. Robert, 2021, International Journal of Infectious Diseases.

Rapid communications A surge of MDR and XDR tuberculosis in France among patients born in the Former Soviet Union

V. Jarlier, F. Brossier, W. Sougakoff, 2013 .

Activities of New Macrolides and Fluoroquinolones against Mycobacterium ulcerans Infection in Mice

V. Jarlier, J. Robert, N. Lounis, 2001, Antimicrobial Agents and Chemotherapy.

Activities of Several Antimicrobials againstMycobacterium ulcerans Infection in Mice

V. Jarlier, J. Grosset, P. Bonnafous, 2000, Antimicrobial Agents and Chemotherapy.

Detection of Antibiotic Resistance in Leprosy Using GenoType LepraeDR, a Novel Ready-To-Use Molecular Test

V. Jarlier, M. Matsuoka, E. Cambau, 2012, PLoS neglected tropical diseases.

Incidence of tuberculous meningitis in France, 2000: a capture-recapture analysis.

V. Jarlier, J. Robert, J. Cailhol, 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Genetic Basis for Natural and Acquired Resistance to the Diarylquinoline R207910 in Mycobacteria

K. Andries, V. Jarlier, W. Sougakoff, 2006, Antimicrobial Agents and Chemotherapy.

Molecular Investigation of Resistance to the Antituberculous Drug Ethionamide in Multidrug-Resistant Clinical Isolates of Mycobacterium tuberculosis

V. Jarlier, F. Brossier, W. Sougakoff, 2010, Antimicrobial Agents and Chemotherapy.

Novel Gyrase Mutations in Quinolone-Resistant and -Hypersusceptible Clinical Isolates of Mycobacterium tuberculosis: Functional Analysis of Mutant Enzymes

V. Jarlier, N. Veziris, C. Truffot-Pernot, 2006, Antimicrobial Agents and Chemotherapy.

Molecular Diagnosis of Fluoroquinolone Resistance in Mycobacterium tuberculosis

V. Jarlier, C. Bernard, F. Brossier, 2014, Antimicrobial Agents and Chemotherapy.

Bacterial resistance to antibiotics in France : a public health priority.

J. Desenclos, J. Carlet, B. Régnier, 2000, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Decolonisation for early control of an outbreak of vancomycin-resistant Enterococcus faecium in a geriatric rehabilitation care facility.

J. Golmard, V. Jarlier, F. Brossier, 2010, The Journal of hospital infection.

Should Moxifloxacin Be Used for the Treatment of Extensively Drug-Resistant Tuberculosis? An Answer from a Murine Model

R. Farinotti, V. Jarlier, N. Veziris, 2010, Antimicrobial Agents and Chemotherapy.

Functional Analysis of DNA Gyrase Mutant Enzymes Carrying Mutations at Position 88 in the A Subunit Found in Clinical Strains of Mycobacterium tuberculosis Resistant to Fluoroquinolones

V. Jarlier, N. Veziris, C. Truffot-Pernot, 2006, Antimicrobial Agents and Chemotherapy.

Imipenem, Meropenem, or Doripenem To Treat Patients with Pseudomonas aeruginosa Ventilator-Associated Pneumonia

Q. Lu, J. Rouby, A. Combes, 2013, Antimicrobial Agents and Chemotherapy.

Endocarditis Due to Neisseria bacilliformis in a Patient with a Bicuspid Aortic Valve

V. Jarlier, O. Benveniste, S. Herson, 2009, Journal of Clinical Microbiology.

Multilocus sequence typing scheme for the Mycobacterium abscessus complex.

Nalin Rastogi, S. Rüsch-Gerdes, S. Brisse, 2014, Research in microbiology.

Molecular Analysis of the embCAB Locus and embR Gene Involved in Ethambutol Resistance in Clinical Isolates of Mycobacterium tuberculosis in France

V. Jarlier, C. Bernard, F. Brossier, 2015, Antimicrobial Agents and Chemotherapy.

Infection à Mycobacterium ulcerans

O. Chosidow, V. Jarlier, J. Grosset, 2000 .

Different Factors Associated with CTX-M-Producing ST131 and Non-ST131 Escherichia coli Clinical Isolates

S. Brisse, V. Jarlier, J. Robert, 2013, PloS one.

Quantitative evaluation of extended-spectrum β-lactamase-producing Escherichia coli strains in the wastewater of a French teaching hospital and relation to patient strain

L. Moulin, V. Jarlier, S. Haenn, 2016, Antimicrobial Resistance & Infection Control.

Genetic and Structural Insights into the Dissemination Potential of the Extremely Broad-Spectrum Class A β-Lactamase KPC-2 Identified in an Escherichia coli Strain and an Enterobacter cloacae Strain Isolated from the Same Patient in France

V. Jarlier, W. Sougakoff, C. Mayer, 2008, Antimicrobial Agents and Chemotherapy.

Twenty years of antimicrobial resistance control programme in a regional multi hospital institution, with focus on emerging bacteria (VRE and CPE)

C. Brun-Buisson, V. Jarlier, S. Fournier, 2012, Antimicrobial Resistance and Infection Control.

Long-term control of carbapenemase-producing Enterobacteriaceae at the scale of a large French multihospital institution: a nine-year experience, France, 2004 to 2012.

C. Brun-Buisson, V. Jarlier, S. Fournier, 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Risk factors for extensive drug resistance in multidrug-resistant tuberculosis cases: a case-case study.

V. Jarlier, C. Bernard, F. Brossier, 2018, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[Beta-lactamase producers and other bacteria: which ones to take into consideration and when? The concept of beta-lactamase inhibitor].

V. Jarlier, 1998, Presse medicale.

Evaluation of excreta management in a large French multi-hospital institution.

V. Jarlier, S. Fournier, S. Nérome, 2015, The Journal of hospital infection.

Mutagenesis in the α3α4 GyrA Helix and in the Toprim Domain of GyrB Refines the Contribution of Mycobacterium tuberculosis DNA Gyrase to Intrinsic Resistance to Quinolones

V. Jarlier, C. Mayer, A. Aubry, 2008, Antimicrobial Agents and Chemotherapy.

Estimating the morbidity and mortality associated with infections due to multidrug-resistant bacteria (MDRB), France, 2012

C. Brun-Buisson, V. Jarlier, B. Coignard, 2016, Antimicrobial Resistance & Infection Control.

Mycobacterium avium Complex Common-Source or Cross-Infection in AIDS Patients Attending the Same Day-Care Facility

C. Katlama, V. Jarlier, C. Truffot-Pernot, 1998, Infection Control & Hospital Epidemiology.

Three-year survey of community-acquired methicillin-resistant Staphylococcus aureus producing Panton-Valentine leukocidin in a French university hospital.

P. Nordmann, T. Naas, V. Jarlier, 2005, The Journal of hospital infection.

Minimal effective dose of oral bedaquiline and activity of a long acting formulation of bedaquiline in the murine model of leprosy Bedaquiline for the treatment of leprosy

K. Andries, V. Jarlier, N. Veziris, 2023, bioRxiv.

Corrigendum to ‘Elaboration of a consensual definition of de-escalation allowing a ranking of β-lactams’ [Clin Microbiol Infec 21 (2015) 649.e1–649.e10]

C. Brun-Buisson, J. Timsit, J. Lucet, 2015 .

Evaluation of the New MB Redox System for Detection of Growth of Mycobacteria

V. Jarlier, C. Truffot-Pernot, E. Cambau, 1999, Journal of Clinical Microbiology.

Sterilizing Activity of Second-Line Regimens Containing TMC207 in a Murine Model of Tuberculosis

K. Andries, V. Jarlier, N. Veziris, 2011, PloS one.

[R207910 (TMC207): a new antibiotic for the treatment of tuberculosis].

K. Andries, V. Jarlier, N. Veziris, 2010, Medecine et maladies infectieuses.

Population Genomics of Mycobacterium leprae Reveals a New Genotype in Madagascar and the Comoros

S. Cole, A. Geluk, V. Jarlier, 2020, Frontiers in Microbiology.

Acquired resistance in Mycobacterium avium complex strains isolated from AIDS patients and beige mice during treatment with clarithromycin.

V. Jarlier, C. Truffot-Pernot, J. Grosset, 1995, The Journal of antimicrobial chemotherapy.

Telacebec (Q203)-containing intermittent oral regimens sterilized mice infected with Mycobacterium ulcerans after only 16 doses

V. Jarlier, N. Veziris, J. Robert, 2020, PLoS neglected tropical diseases.

[Resistance to antituberculous drugs].

V. Jarlier, W. Sougakoff, N. Veziris, 2005, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

Impact of Fluoroquinolone Resistance on Bactericidal and Sterilizing Activity of a Moxifloxacin-Containing Regimen in Murine Tuberculosis

V. Jarlier, F. Brossier, N. Veziris, 2013, Antimicrobial Agents and Chemotherapy.

Superficial community‐acquired skin infections: prevalence of bacteria and antibiotic susceptibility in France

V. Jarlier, G. Lorette, P. Beaulieu, 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

Complete Nucleotide Sequence of the First KPC-2- and SHV-12-Encoding IncX Plasmid, pKpS90, from Klebsiella pneumoniae

S. Brisse, L. Frangeul, V. Jarlier, 2012, Antimicrobial Agents and Chemotherapy.

[Antibiotic susceptibility of Staphylococcus aureus strains responsible for community-acquired skin infections].

V. Jarlier, P. Bernard, A. Santerre-Henriksen, 2008, Annales de dermatologie et de venereologie.

Treatment outcomes of patients with multidrug-resistant and extensively drug resistant tuberculosis in Hunan Province, China

K. Alene, E. McBryde, V. Jarlier, 2017, BMC Infectious Diseases.

[Multi-resistant tuberculosis in France].

V. Jarlier, J. Robert, 2002, Revue des maladies respiratoires.

Progressing towards tuberculosis elimination in the European Union and European Economic Area.

O. Nyrén, A. Plymoth, A. Páldy, 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Impacts of Dosing Frequency of the Combination Rifampin-Streptomycin on Its Bactericidal and Sterilizing Activities against Mycobacterium ulcerans in Mice

V. Jarlier, J. Robert, B. Ji, 2009, Antimicrobial Agents and Chemotherapy.

Identification of Mycobacterial Species by PCR Sequencing of Quinolone Resistance-Determining Regions of DNA Gyrase Genes

J. Dauendorffer, V. Jarlier, W. Sougakoff, 2003, Journal of Clinical Microbiology.

Prospective study on antimicrobial resistance in leprosy cases diagnosed in France from 2001 to 2015.

V. Jarlier, A. Aubry, E. Cambau, 2018, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Legionella wadsworthii pneumonia: gram stain usefulness.

C. Morélot-Panzini, T. Similowski, V. Jarlier, 2011, Medecine et maladies infectieuses.

Elaboration of a consensual definition of de-escalation allowing a ranking of β-lactams.

C. Brun-Buisson, J. Timsit, J. Lucet, 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Molecular Analysis of the embCAB Locus and embR Gene Involved in Ethambutol Resistance in Clinical Isolates of Mycobacterium tuberculosis in France

V. Jarlier, C. Bernard, F. Brossier, 2015, Antimicrobial Agents and Chemotherapy.

Molecular Diagnosis of Fluoroquinolone Resistance in Mycobacterium tuberculosis

V. Jarlier, C. Bernard, F. Brossier, 2014, Antimicrobial Agents and Chemotherapy.

[Analysis of restriction fragment length polymorphism (RFLP) of Mycobacterium tuberculosis strains isolated from patients with several episodes of tuberculosis].

V. Jarlier, W. Sougakoff, J. Grosset, 1996, Pathologie-biologie.

Illustration of the Difficulty of Identifying Streptococcus equi Strains at the Subspecies Level through a Case of Endocarditis in an Immunocompetent Man

V. Jarlier, F. Brossier, A. Renvoisé, 2013, Journal of Clinical Microbiology.

Impact of Fluoroquinolone Resistance on Bactericidal and Sterilizing Activity of a Moxifloxacin-Containing Regimen in Murine Tuberculosis

V. Jarlier, F. Brossier, N. Veziris, 2013, Antimicrobial Agents and Chemotherapy.

Comparison of methods available for identification of Mycobacterium chimaera.

L. Moulin, V. Jarlier, S. Haenn, 2017, Clinical Microbiology and Infection.

Q203 containing fully intermittent oral regimens exhibited high sterilizing activity against Mycobacterium ulcerans in mice

V. Jarlier, N. Veziris, J. Robert, 2019, bioRxiv.

O477 Evaluation of a new version of the “RT-TB” triplex real-time PCR assay for the rapid diagnosis of Mycobacterium tuberculosis in clinical samples

V. Jarlier, F. Brossier, W. Sougakoff, 2007 .

[Histopathological study of Mycobacterium marinum infection].

O. Chosidow, V. Jarlier, E. Caumes, 2011, Annales de dermatologie et de vénéréologie.

Helicobacter cinaedi bacteraemia in an HIV-infected patient.

F. Mégraud, V. Jarlier, E. Caumes, 2015, Medecine et maladies infectieuses.

Impacts of Dosing Frequency of the Combination Rifampin-Streptomycin on Its Bactericidal and Sterilizing Activities against Mycobacterium ulcerans in Mice

V. Jarlier, J. Robert, B. Ji, 2009, Antimicrobial Agents and Chemotherapy.

Extended measures for controlling an outbreak of VIM-1 producing imipenem-resistant Klebsiella pneumoniae in a liver transplant centre in France, 2003-2004.

V. Jarlier, F. Saliba, A. Carbonne, 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Curbing methicillin-resistant Staphylococcus aureus in 38 French hospitals through a 15-year institutional control program.

C. Brun-Buisson, J. Carlet, J. Lucet, 2010, Archives of internal medicine.